November 19, 2024
Nov. 19, 2024 — President-elect Donald J. Trump has said that he would nominate Dr. Mehmet Oz to serve as administrator of the Centers for Medicare […]
November 19, 2024
On This Page Date: January 22, 2025 Time: 1:00 PM – 3:00 PM ET AGENDA Visit CDER Small Business and Industry Assistance Page ABOUT THIS EVENT […]
November 19, 2024
For Immediate Release: November 19, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the […]
November 19, 2024
[embedded content] Español 中文 Tagalog Tiếng Việt 한국어 Today you have several treatment options to prevent hospitalization and other serious complications of COVID-19. The U.S. Food and Drug Administration has […]
November 19, 2024
The routine administration of spironolactone to patients after a myocardial infarction (MI) did not reduce either of the coprimary outcomes in the CLEAR SYNERGY (OASIS 9) […]
November 19, 2024
Summary Company Announcement Date: November 18, 2024 FDA Publish Date: November 19, 2024 Product Type: Drugs Reason for Announcement: Recall Reason Description Mislabeled with the incorrect […]
November 19, 2024
Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research and Theresa Michele, M.D., Director, CDER Office of New Drugs’ Office of Nonprescription Drugs CDER Director, […]
November 19, 2024
TOPLINE: A multi-step survey revealed that priorities of people living with type 1 diabetes (T1D) include the ongoing need for research and treatments in the areas […]
November 19, 2024
WASHINGTON, DC — Use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduced the need for urate-lowering therapy (ULT) and gout flare therapies in people who had both type […]